PrEP has been instrumental in lowering HIV rates around the world. But a decade on, tariffs, trade wars and sweeping US funding cuts are putting its future in doubt. Brandon Bentley reports.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.